ArticleJournal of thoracic disease2023

Effectiveness and safety of camrelizumab-containing neoadjuvant therapy in patients with esophageal squamous cell carcinoma: a prospective multicenter observational cohort study.

Yi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.